Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer

BACKGROUND: Our previous study reported the favorable efficacy and good tolerance associated with a modified XELOX adjuvant chemotherapy with eight cycles of capecitabine and six cycles of oxaliplatin for operated stage III colon cancer. The current study aimed to confirm the feasibility of modified...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Peng, Jianhong, Li, Weihao, Fan, Wenhua, Zhou, Wenhao, Zhu, Ying, Li, Xueying, Pan, Zhizhong, Lin, Xiaoping, Lin, Junzhong
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543913/
https://ncbi.nlm.nih.gov/pubmed/33071795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.583091
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars